8-K
Current Report
WEST PHARMACEUTICAL SERVICES INC Filed Acc 0000105770-07-000368
Exit or restructuring costs · Impairment · Executive or director change · Bylaws or fiscal year change
- Item 2.05 Costs associated with exit or disposal activities
- Item 2.06 Material impairments
- Item 5.02 Departure or appointment of directors or officers
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading file8k.htm…